ヘリオスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2018/11/14 | 1,995 | 2,180 | 1,995 | 2,019 | +32 | +1.6% | 299,700 |
2018/11/13 | 1,892 | 1,989 | 1,868 | 1,987 | +19 | +1% | 152,100 |
2018/11/12 | 1,896 | 2,000 | 1,863 | 1,968 | +86 | +4.6% | 352,100 |
2018/11/09 | 1,934 | 1,945 | 1,789 | 1,882 | -62 | -3.2% | 191,200 |
2018/11/08 | 1,850 | 1,950 | 1,845 | 1,944 | +118 | +6.5% | 348,400 |
2018/11/07 | 1,788 | 1,833 | 1,773 | 1,826 | +41 | +2.3% | 193,600 |
2018/11/06 | 1,689 | 1,806 | 1,678 | 1,785 | +110 | +6.6% | 192,900 |
2018/11/05 | 1,640 | 1,725 | 1,626 | 1,675 | +26 | +1.6% | 98,900 |
2018/11/02 | 1,580 | 1,670 | 1,580 | 1,649 | +63 | +4% | 118,700 |
2018/11/01 | 1,595 | 1,607 | 1,558 | 1,586 | -9 | -0.6% | 45,800 |
2018/10/31 | 1,564 | 1,600 | 1,554 | 1,595 | +49 | +3.2% | 49,500 |
2018/10/30 | 1,500 | 1,584 | 1,495 | 1,546 | +9 | +0.6% | 74,300 |
2018/10/29 | 1,519 | 1,543 | 1,496 | 1,537 | +18 | +1.2% | 50,100 |
2018/10/26 | 1,550 | 1,550 | 1,470 | 1,519 | -7 | -0.5% | 153,300 |
2018/10/25 | 1,612 | 1,613 | 1,526 | 1,526 | -126 | -7.6% | 86,100 |
2018/10/24 | 1,685 | 1,693 | 1,630 | 1,652 | -14 | -0.8% | 31,500 |
2018/10/23 | 1,702 | 1,702 | 1,628 | 1,666 | -15 | -0.9% | 45,100 |
2018/10/22 | 1,658 | 1,683 | 1,626 | 1,681 | +6 | +0.4% | 33,800 |
2018/10/19 | 1,663 | 1,686 | 1,642 | 1,675 | -5 | -0.3% | 20,400 |
2018/10/18 | 1,663 | 1,684 | 1,651 | 1,680 | +36 | +2.2% | 23,200 |
2018/10/17 | 1,610 | 1,644 | 1,607 | 1,644 | +36 | +2.2% | 19,300 |
2018/10/16 | 1,609 | 1,620 | 1,592 | 1,608 | -9 | -0.6% | 25,900 |
2018/10/15 | 1,621 | 1,651 | 1,610 | 1,617 | -44 | -2.6% | 41,500 |
2018/10/12 | 1,615 | 1,678 | 1,600 | 1,661 | +36 | +2.2% | 38,900 |
2018/10/11 | 1,647 | 1,666 | 1,602 | 1,625 | -69 | -4.1% | 104,000 |
2018/10/10 | 1,681 | 1,709 | 1,663 | 1,694 | +20 | +1.2% | 59,800 |
2018/10/09 | 1,733 | 1,733 | 1,665 | 1,674 | -39 | -2.3% | 33,600 |
2018/10/05 | 1,731 | 1,733 | 1,707 | 1,713 | -42 | -2.4% | 50,400 |
2018/10/04 | 1,792 | 1,793 | 1,712 | 1,755 | -35 | -2% | 82,800 |
2018/10/03 | 1,802 | 1,819 | 1,780 | 1,790 | +3 | +0.2% | 64,600 |
2018/10/02 | 1,835 | 1,855 | 1,785 | 1,787 | -40 | -2.2% | 57,300 |
2018/10/01 | 1,790 | 1,838 | 1,771 | 1,827 | +30 | +1.7% | 53,200 |
2018/09/28 | 1,845 | 1,861 | 1,765 | 1,797 | -37 | -2% | 116,600 |
2018/09/27 | 1,845 | 1,861 | 1,821 | 1,834 | -5 | -0.3% | 85,300 |
2018/09/26 | 1,831 | 1,861 | 1,831 | 1,839 | +12 | +0.7% | 157,000 |
2018/09/25 | 1,785 | 1,849 | 1,781 | 1,827 | +81 | +4.6% | 238,300 |
2018/09/21 | 1,679 | 1,747 | 1,673 | 1,746 | +67 | +4% | 95,300 |
2018/09/20 | 1,689 | 1,703 | 1,662 | 1,679 | -25 | -1.5% | 47,000 |
2018/09/19 | 1,730 | 1,743 | 1,677 | 1,704 | -65 | -3.7% | 92,200 |
2018/09/18 | 1,762 | 1,784 | 1,741 | 1,769 | -9 | -0.5% | 43,700 |
2018/09/14 | 1,702 | 1,778 | 1,654 | 1,778 | +116 | +7% | 92,600 |
2018/09/13 | 1,663 | 1,690 | 1,625 | 1,662 | -18 | -1.1% | 64,400 |
2018/09/12 | 1,714 | 1,721 | 1,658 | 1,680 | -48 | -2.8% | 45,100 |
2018/09/11 | 1,718 | 1,739 | 1,715 | 1,728 | -17 | -1% | 32,300 |
2018/09/10 | 1,732 | 1,759 | 1,725 | 1,745 | +8 | +0.5% | 20,600 |
2018/09/07 | 1,743 | 1,745 | 1,695 | 1,737 | -18 | -1% | 60,500 |
2018/09/06 | 1,796 | 1,804 | 1,755 | 1,755 | -49 | -2.7% | 48,100 |
2018/09/05 | 1,795 | 1,810 | 1,782 | 1,804 | -7 | -0.4% | 44,800 |
2018/09/04 | 1,794 | 1,813 | 1,780 | 1,811 | +9 | +0.5% | 48,000 |
2018/09/03 | 1,820 | 1,820 | 1,774 | 1,802 | -21 | -1.2% | 75,500 |
1651~
1700
件表示中 / 2491件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ヘリオス | 57,300円 | +150.0% | - | 0.00% | - | 52.71倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
JCRファーマ | 62,900円 | +14.3% | - | 3.18% | 25.57倍 | 1.63倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 254,000円 | +16.9% | +33.2% | 2.17% | 13.87倍 | 1.10倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
クオリプス | 739,000円 | +237.1% | - | 0.00% | - | 11.01倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
タウンズ | 58,300円 | +11.5% | -0.9% | 4.80% | 6.98倍 | 3.45倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
市場注目の銘柄
チャート関連のコラム